Demos

Demos is an early-stage biotechnology company focused on the intersection of decentralized science (DeSci) and longevity research. The company operates as a platform designed to democratize drug discovery and development by leveraging blockchain technology to coordinate funding, data sharing, and intellectual property management. Demos aims to accelerate the development of therapeutics for aging and age-related diseases by creating a community-driven ecosystem for researchers and investors. Their approach focuses on increasing transparency and efficiency in the traditional biotech R&D pipeline through decentralized governance and incentive structures.